Li Tao, Deputy Director of the National Medical Insurance Administration, attended the opening ceremony of the 8th China International Import Expo in Shanghai.

On November 4th-5th, 2025, Li Tao, a member of the Party Group and Deputy Director of the National Medical Insurance Administration, went to Shanghai to attend the opening ceremony of the 8th China International Import Expo. He also visited some exhibition areas of imported pharmaceutical companies on-site, introducing relevant measures of China's medical insurance to support the development of pharmaceutical innovation, and communicating with related pharmaceutical companies. Li Tao pointed out that the Fourth Plenary Session of the 20th Central Committee of the Party clearly stated the need to support the development of innovative drugs and medical devices. The National Medical Insurance Administration deeply studies and implements the spirit of the Fourth Plenary Session of the 20th Central Committee, dynamically adjusts the drug list for medical insurance, formulates a list of innovative drugs for commercial insurance, promotes the construction of a diversified payment pattern for innovative drugs, carries out comprehensive value evaluation of medical insurance in the real world, better serves people's health, empowers the high-quality development of the pharmaceutical industry. We welcome multinational companies to introduce advanced drugs, devices, and technologies into China, actively integrate into the overall development of China's modernization.